The biggest challenge of any pharma is availability. They don't make money if the product doesn't get the FDA's blessing and they can distribute the product.
STSI has already bypassed that problem because of being a supplement (for now).
And really there is no good excuse for why sales are so disappointing. If it really worked it would be growing through word of mouth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.